Comparing center-based and home-based treatment for young children with autism
Official title: Randomized Controlled Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism
Run by Stanford University · NCT04899544 · Data updated 2026-11-12
This study tests whether treatment for young children with autism works better when done at a center or at home, focusing on improving their language and social skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years to 5 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Stanford, California) |
| Status | Recruiting |
| Started | October 18, 2022 |
| Main results expected | September 15, 2028 |
| Study ends | September 15, 2028 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT04899544 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 2 to 5 years diagnosed with autism spectrum disorder and experiencing significant language delays.
✕Probably not a fit
Patients who do not have a diagnosis of autism spectrum disorder or who are not experiencing language delays may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of two different approaches to Pivotal Response Treatment (PRT) for young children with autism spectrum disorder (ASD) who have significant language delays. Participants will be divided into two groups: one receiving center-based PRT and the other receiving home-based PRT, with a control group receiving treatment as usual. The study will last for 16 weeks and will assess improvements in social communication skills. The trial will utilize standardized assessments to measure language abilities and social communication outcomes.
Why it matters
Potential benefit: If successful, this study could provide insights into the most effective treatment settings for improving communication skills in young children with autism.
How similar studies have gone: Previous studies have shown varying success with Pivotal Response Treatment, but this specific comparison of center-based versus home-based approaches is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview Revised (ADI-R), Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) or Childhood Autism Rating Scale, Second Edition (CARS-2), Diagnostic and Statistical Manual 5th Edition (DSM-5), and expert clinical opinion; * Boys and girls between 2.0 and 5.11 years; * Ability to participate in the testing procedures to the extent that valid standard scores can be obtained; * Language delay as measured by the Preschool Language Scale, 5th Edition (PLS-5): Standard score at least 1 standard deviation below average for expressive language ability for 2 and 3 year olds; 2 standard deviations for 4 year olds, and 3 standard deviations for 5 year olds; * Stable treatment (e.g., Applied Behavior Analysis - ABA), speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements; * No anticipated changes on treatment during study participation for Center-Based Pivotal Response Treatment (PRT-C) and In-Home Pivotal Response Treatment (PRT-H); * No more than 60 minutes of individual 1:1 speech therapy per week; * Availability of at least one parent or primary caregiver who can consistently participate in parent training and research measures. Exclusion Criteria: * Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.); * Receiving ABA of 15 hours or more; * Presence of active medical problem (e.g., unstable seizure disorder or heart disease); * Previous adequate Pivotal Response Treatment (PRT) trial; * Participants living more than 30 miles from Stanford University; * Child's primary language other than English.
Where it's running
-
Stanford University School of Medicine
Stanford, California, United States Recruiting
Study contacts
- Principal investigator: Antonio Y. Hardan, MD — Stanford University
- Study coordinator: Beatrice Begley
- Email: PALprogram@stanford.edu
- Phone: (650)736-1235
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AdiaVita and glutathione for autism in kids and teens
This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.
-
Do AdiaVita stem cells plus glutathione help kids with autism more than glutathione alone?
This 12-month study tests whether adding AdiaVita stem cells and exosomes to glutathione helps children aged 3–12 with autism more than glutathione alone.
-
Online test of BlinkLab Dx1 for autism in kids aged 2–11
This study tests whether the BlinkLab Dx1 smartphone app can help identify autism in children aged 2 to 11 by comparing app-based measurements with prior clinical diagnoses.
-
Trauma‑Focused Cognitive Behavioral Therapy adapted for autistic children and teens (pilot implementation)
This pilot will try TF‑CBT adapted for autistic children and teens with trauma-related symptoms to see if community mental health clinicians can deliver it and families find it acceptable.
-
CRUSH curriculum for romance and sexual health for autistic young adults
This project will try the CRUSH program—a group course plus one-to-one coaching—to teach sexual health and dating skills to autistic adults ages 18 to 30.
-
Static balance testing in children with autism using a virtual reality system
This project tests whether a virtual reality rehabilitation system can measure static balance differences in children with autism aged 6–10.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.